Bristol-Myers Squibb

After the breakup: the end of a partnership with big pharma brings both opportunity and challenge for biotech firms
Chemical and Engineering News
Fri, 06/24/11 - 10:17 am
Exelixis
Bristol-Myers Squibb
Blood-thinner study shakes Big Pharma stocks
Marketwatch
Thu, 06/23/11 - 06:48 pm
blood thinners
Pfizer
JNJ
Sanofi
Bristol-Myers Squibb
Bristol-Myers Diabetes Drug Draws Scrutiny After Avandia, Actos
Bloomberg
Thu, 06/23/11 - 09:12 am
Avandia
diabetes
Bristol-Myers Squibb
Actos
Takeda
AstraZeneca
Dapagliflozin
Pfizer, Bristol-Myers Blood Thinner Tops Warfarin in Stroke
Bloomberg
Thu, 06/23/11 - 08:55 am
Warfarin
Pfizer
blood thinners
Bristol-Myers Squibb
Apixaban
Best Healthcare Sector Dividend Stocks
Seeking Alpha
Tue, 06/21/11 - 09:48 pm
dividends
AstraZeneca
Bristol-Myers Squibb
Trinity Biotech
When Two Cancer Drugs Are Better Than One
Bloomberg Businessweek
Fri, 06/17/11 - 10:17 am
Merck
AstraZeneca
Eli Lilly
Roche
GSK
Takeda
cancer
Bristol-Myers Squibb
Analysis: Data may help Bristol/Pfizer clot drug catch rivals
CNBC
Fri, 06/17/11 - 09:42 am
Pfizer
blood thinners
Bristol-Myers Squibb
Apixaban
Boehringer Ingelheim
Pradaxa
JNJ
Xarelto
Bayer
Are Two FDA Approvals in One Week a Positive Sign?
Motley Fool
Thu, 06/16/11 - 10:12 pm
FDA
Nulojix
kidney transplant
Bristol-Myers Squibb
GSK
Valeant Pharmaceuticals
Potiga
epilepsy
Off a Cliff: $100 Billion in Revenues Will Disappear From Drug Business by 2013
BNET Pharma
Thu, 06/16/11 - 12:29 pm
patents
generics
Pfizer
Eli Lilly
Bristol-Myers Squibb
GSK
Novartis
AstraZeneca
Merck
Sanofi
JNJ
Forest Labs
Bristol-Myers gets FDA OK on new transplant drug
Yahoo/AP
Wed, 06/15/11 - 09:31 pm
FDA
transplant drugs
Bristol-Myers Squibb
Can Biocon get a $1B pharma deal for its oral insulin program?
Fierce Biotech
Wed, 06/15/11 - 09:01 am
insulin
diabetes
Biocon
India
Sanofi
Bristol-Myers Squibb
Bristol-Myers Squibb, Sanofi-Aventis in race for drug marketing pact with Biocon
Economic Times, India
Tue, 06/14/11 - 09:13 am
Bristol-Myers Squibb
Sanofi
India
Biocon
7 Pharmaceuticals Awaiting FDA Decisions This Week
Seeking Alpha
Sun, 06/12/11 - 11:12 am
GSK
Valeant Pharmaceuticals
Bristol-Myers Squibb
Acura Pharmaceuticals
Regeneron
Bayer
Barclays on U.S. Major Pharmaceuticals: Pipelines Revived? Making Strides in Oncology, Cardiology, and Virology
Street Insider
Sat, 06/11/11 - 11:01 am
Bristol-Myers Squibb
Pfizer
Big Pharma
pipelines
Bristol-Myers Squibb's Dividend Is Safe
Motley Fool
Sat, 06/11/11 - 10:45 am
Bristol-Myers Squibb
5-Star Stocks Poised to Pop: Bristol-Myers
Motley Fool
Thu, 06/9/11 - 11:33 am
Bristol-Myers Squibb
A Dull ASCO And The Usual Sell-Off
Investopedia
Tue, 06/7/11 - 07:34 pm
ASCO
Celgene
Bristol-Myers Squibb
Incyte
Exelixis
Novartis
YM BioSciences
Neoprobe
Second Phase 3 Study of YERVOY™ (ipilimumab) in Metastatic Melanoma Meets Primary Endpoint of Overall Survival
Yahoo/BusinessWire
Sun, 06/5/11 - 10:45 am
Yervoy
Bristol-Myers Squibb
melanoma
Roche, Bristol Melanoma Drugs Shine
The Street
Sun, 06/5/11 - 10:39 am
Roche
Bristol-Myers Squibb
melanoma
vemurafenib
Yervoy
Five-Year Follow-Up Data for SPRYCEL® (dasatinib) 100 mg Once Daily Demonstrated 78 Percent Overall Survival in Patients with Chronic-Phase Chronic Myeloid Leukemia Resistant or Intolerant to Gleevec®*
BusinessWire
Sat, 06/4/11 - 10:53 am
Sprycel
Bristol-Myers Squibb
leukemia

Pages